Ohno T - Search Results

1

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

Lau JY, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Lau JY, et al. Among authors: ohno t. Lancet. 1993 Nov 13;342(8881):1208-9. doi: 10.1016/0140-6736(93)92187-x. Lancet. 1993. PMID: 7901531 Clinical Trial.

2

Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.

Lau JY, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP, et al. Lau JY, et al. Among authors: ohno t. J Infect Dis. 1995 Feb;171(2):281-9. doi: 10.1093/infdis/171.2.281. J Infect Dis. 1995. PMID: 7844363

3

Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

González-Peralta RP, Qian K, She JY, Davis GL, Ohno T, Mizokami M, Lau JY. González-Peralta RP, et al. Among authors: ohno t. J Med Virol. 1996 Jul;49(3):242-7. doi: 10.1002/(SICI)1096-9071(199607)49:3<242::AID-JMV14>3.0.CO;2-E. J Med Virol. 1996. PMID: 8818972

4

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JY. Nelson DR, et al. Among authors: ohno t. Hepatology. 1998 Jul;28(1):225-30. doi: 10.1002/hep.510280129. Hepatology. 1998. PMID: 9657116

5

Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.

Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY. Orito E, et al. Among authors: ohno t. J Med Virol. 1995 Jun;46(2):109-15. doi: 10.1002/jmv.1890460205. J Med Virol. 1995. PMID: 7636496

6

Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.

Mizokami M, Orito E, Gibo Y, Suzuki K, Ohba K, Ohno T, Lau JY. Mizokami M, et al. Among authors: ohno t. Liver. 1996 Feb;16(1):23-7. doi: 10.1111/j.1600-0676.1996.tb00699.x. Liver. 1996. PMID: 8868074

7

Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibrium.

Mizokami M, Ohno T, Ohba K, Davis GL, Suzuki K, Orito E, Lau JY. Mizokami M, et al. Among authors: ohno t. Antivir Ther. 1999;4(1):15-9. Antivir Ther. 1999. PMID: 10682124

8

Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China.

Wu RR, Mizokami M, Lau JY, Ohno T, Fang ZX, Ohba K, Wu XS, Hata A, Sasaki M, Iino S. Wu RR, et al. Among authors: ohno t. J Med Virol. 1995 Feb;45(2):174-8. doi: 10.1002/jmv.1890450211. J Med Virol. 1995. PMID: 7775935

9

Vertical transmission of hepatitis C.

Gish RG, Cox KL, Mizokami M, Ohno T, Lau JY. Gish RG, et al. Among authors: ohno t. J Pediatr Gastroenterol Nutr. 1996 Jan;22(1):118-9. doi: 10.1097/00005176-199601000-00026. J Pediatr Gastroenterol Nutr. 1996. PMID: 8788304 No abstract available.

10

The "gold-standard," accuracy, and the current concepts: hepatitis C virus genotype and viremia.

Ohno T, Lau JY. Ohno T, et al. Hepatology. 1996 Nov;24(5):1312-5. doi: 10.1002/hep.510240552. Hepatology. 1996. PMID: 8903414 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,600 results

Search Page

Filters